TraceLink’s Post

30 sessions, 2 days, countless insights. FutureLink unites visionaries from across the life sciences and healthcare supply chain to share actionable ideas and strategies. Register now and save $200 with code FUTURE200: https://bit.ly/3UIpswK #supplychain #pharma #futurelink

30 sessions, 2 days, countless insights. FutureLink unites visionaries from across the life sciences and healthcare supply chain to share actionable ideas and strategies. Register now and save $200 with code FUTURE200: https://bit.ly/3UIpswK #supplychain #pharma #futurelink

30 sessions, 2 days, countless insights. FutureLink unites visionaries from across the life sciences and healthcare supply chain to share actionable ideas and strategies. Register now and save $200 with code FUTURE200: https://bit.ly/3UIpswK #supplychain #pharma #futurelink

30 sessions, 2 days, countless insights. FutureLink unites visionaries from across the life sciences and healthcare supply chain to share actionable ideas and strategies. Register now and save $200 with code FUTURE200: https://bit.ly/3UIpswK #supplychain #pharma #futurelink

This is promising to be one of our best years yet, covering exiting new innovations in the life sciences and healthcare supply chain. I'll be on-site showcasing some exiting new enhancements for our Multienterprise Information Network Tower (MINT) solution to integrate with your existing ERP, WMS, and more. #futurelink #tracelink #supplychain

30 sessions, 2 days, countless insights. FutureLink unites visionaries from across the life sciences and healthcare supply chain to share actionable ideas and strategies. Register now and save $200 with code FUTURE200: https://bit.ly/3UIpswK #supplychain #pharma #futurelink

Understanding the therapeutic area, patient journey, and product requirements is just the start to building a comprehensive patient support and product distribution strategy. JM DREW clients value our strategic approach and recognize us as an extension of their commercial planning teams. Learn more at navigateaccess.com. #NavigateAccess #MarketAccess #PatientSupport #Pharma #Biotech

More than half of #pharma companies are starting #MarketAccess planning by Phase II or III, and 33% are beginning even earlier, in Phase I. https://ow.ly/VJgo50Su4XA Learn how pharma is coping with increased financial pressures in this 2024 State of Patient Access Survey report.

The global edition of PatientView's 'Corporate Reputation of Pharma 2023/4' report will be released on Monday, April 29th! Based on feedback and opinions from 2,500+ patient groups worldwide to support pharma companies in becoming more patient-centric.

Our experience at S-K indicates that Gross-to-Net pricing is often an overlooked tool in revenue growth, kept as a second thought over launch price optimization and reimbursement price setting. Yet, GtN when applied correctly can yield significant benefits to revenue and profitability. Some questions to ask yourselves.. ❓When was the last time you had a close look into discounting/rebate practices within your local teams? ❓Are your GtN investments strategically (and rationally) allocated across accounts of different segments? ❓Should you increase of decrease GtN investments for your key products given changing competitive dynamics? ❓Do you lack visibility into the 'true' net prices across your portfolio? My colleagues Christian Rebholz and Tim Kohtes, and I shared our thoughts in a recent article published by Simon-Kucher. (We are also offering limited Lunch-and-Learn sessions to engage with your team's and share best practices from our experience.)